LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

Search

Globus Medical Inc (Class A)

Slēgts

SektorsVeselības aprūpe

83.77 -0.78

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

83.4

Max

85.77

Galvenie mērījumi

By Trading Economics

Ienākumi

-84M

119M

Pārdošana

24M

769M

P/E

Sektora vidējais

27.948

105.69

EPS

1.18

Peļņas marža

15.469

Darbinieki

5,300

EBITDA

22M

215M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+7.3% upside

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

3.3B

12B

Iepriekšējā atvēršanas cena

84.55

Iepriekšējā slēgšanas cena

83.77

Ziņu noskaņojums

By Acuity

67%

33%

328 / 374 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

Globus Medical Inc (Class A) Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 13. nov. 21:34 UTC

Peļņas

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

2025. g. 13. nov. 23:45 UTC

Tirgus saruna

Nikkei May Fall After Wall Street's Weakness -- Market Talk

2025. g. 13. nov. 23:42 UTC

Iegādes, apvienošanās, pārņemšana

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

2025. g. 13. nov. 23:41 UTC

Tirgus saruna

Gold Edges Higher on Possible Dip-Buying -- Market Talk

2025. g. 13. nov. 23:24 UTC

Peļņas

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

2025. g. 13. nov. 23:24 UTC

Peļņas

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

2025. g. 13. nov. 23:23 UTC

Peļņas

JBS NV 3Q EPS 52c >JBS

2025. g. 13. nov. 23:23 UTC

Peļņas

JBS NV 3Q Sales $22.6B >JBS

2025. g. 13. nov. 23:04 UTC

Tirgus saruna

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

2025. g. 13. nov. 22:02 UTC

Peļņas

Nu Holdings 3Q Net $783M >NU

2025. g. 13. nov. 22:01 UTC

Peļņas

Nu Holdings 3Q Rev $4.2B >NU

2025. g. 13. nov. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

2025. g. 13. nov. 21:50 UTC

Peļņas

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

2025. g. 13. nov. 21:45 UTC

Iegādes, apvienošanās, pārņemšana

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

2025. g. 13. nov. 21:41 UTC

Iegādes, apvienošanās, pārņemšana

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

2025. g. 13. nov. 21:36 UTC

Iegādes, apvienošanās, pārņemšana

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

2025. g. 13. nov. 21:36 UTC

Iegādes, apvienošanās, pārņemšana

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

2025. g. 13. nov. 21:36 UTC

Iegādes, apvienošanās, pārņemšana

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

2025. g. 13. nov. 21:36 UTC

Iegādes, apvienošanās, pārņemšana

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

2025. g. 13. nov. 21:36 UTC

Iegādes, apvienošanās, pārņemšana

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

2025. g. 13. nov. 21:33 UTC

Tirgus saruna

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

2025. g. 13. nov. 21:33 UTC

Peļņas

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

2025. g. 13. nov. 21:31 UTC

Peļņas

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

2025. g. 13. nov. 21:25 UTC

Peļņas

Figure Tech Solutions 3Q Rev $156.4M >FIGR

2025. g. 13. nov. 21:25 UTC

Peļņas

Figure Tech Solutions 3Q EPS 34c >FIGR

2025. g. 13. nov. 21:23 UTC

Peļņas

Intchains Group 3Q Rev $1.3M >ICG

2025. g. 13. nov. 21:03 UTC

Peļņas

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

2025. g. 13. nov. 21:02 UTC

Peļņas

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

2025. g. 13. nov. 21:01 UTC

Peļņas

Applied Materials 4Q Rev $6.8B >AMAT

2025. g. 13. nov. 21:01 UTC

Peļņas

Applied Materials 4Q Gross Margin 48.0% >AMAT

Salīdzinājums

Cenas izmaiņa

Globus Medical Inc (Class A) Prognoze

Cenas mērķis

By TipRanks

7.3% augšup

Prognoze 12 mēnešiem

Vidējais 90.89 USD  7.3%

Augstākais 114 USD

Zemākais 64 USD

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Globus Medical Inc (Class A) — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

12 ratings

8

Pirkt

4

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

72.18 / 73.07Atbalsts un pretestība

Īstermiņā

Bullish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Weak Bearish Evidence

Noskaņojums

By Acuity

328 / 374 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat